DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,930,720 | -4.8% | 16,378 | 0.0% | 0.08% | -4.6% |
| Q1 2023 | $4,127,910 | -5.0% | 16,378 | 0.0% | 0.09% | -10.3% |
| Q4 2022 | $4,347,048 | +2.8% | 16,378 | 0.0% | 0.10% | -8.5% |
| Q3 2022 | $4,229,000 | +1.9% | 16,378 | 0.0% | 0.11% | +17.8% |
| Q2 2022 | $4,152,000 | -13.6% | 16,378 | 0.0% | 0.09% | -5.3% |
| Q1 2022 | $4,804,000 | -10.9% | 16,378 | 0.0% | 0.10% | -8.7% |
| Q4 2021 | $5,389,000 | +438.9% | 16,378 | +398.6% | 0.10% | +420.0% |
| Q3 2021 | $1,000,000 | +13.5% | 3,285 | 0.0% | 0.02% | +11.1% |
| Q2 2021 | $881,000 | -62.5% | 3,285 | -68.5% | 0.02% | -66.7% |
| Q1 2021 | $2,349,000 | -71.4% | 10,441 | -71.7% | 0.05% | -73.3% |
| Q4 2020 | $8,205,000 | -30.7% | 36,936 | -32.8% | 0.20% | -39.2% |
| Q3 2020 | $11,833,000 | +21.7% | 54,955 | 0.0% | 0.33% | +9.2% |
| Q2 2020 | $9,720,000 | +7.7% | 54,955 | -15.7% | 0.30% | -5.0% |
| Q1 2020 | $9,022,000 | -18.3% | 65,169 | -9.4% | 0.32% | -10.4% |
| Q4 2019 | $11,043,000 | +6.3% | 71,951 | 0.0% | 0.36% | +5.0% |
| Q3 2019 | $10,391,000 | +1.1% | 71,951 | 0.0% | 0.34% | -0.3% |
| Q2 2019 | $10,283,000 | +8.3% | 71,951 | 0.0% | 0.34% | +10.7% |
| Q1 2019 | $9,498,000 | +160.9% | 71,951 | +103.8% | 0.31% | +129.9% |
| Q4 2018 | $3,640,000 | -5.1% | 35,299 | 0.0% | 0.13% | +21.8% |
| Q3 2018 | $3,836,000 | – | 35,299 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |